AAAAAA

   
Results: 1-9 |
Results: 9

Authors: GABEL RA KIVLIGHN SD ZINGARO GJ SCHORN TW SCHAFFER LW ASHTON WT CHANG LL FLANAGAN K GREENLEE WJ SIEGL PKS
Citation: Ra. Gabel et al., IN-VIVO PHARMACOLOGY OF L-159,913, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Clinical and experimental hypertension, 17(6), 1995, pp. 931-953

Authors: KIVLIGHN SD ZINGARO GJ GABEL RA BROTEN TP SCHORN TW SCHAFFER LW NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., IN-VIVO PHARMACOLOGY OF A NOVEL AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, MK-996, American journal of hypertension, 8(1), 1995, pp. 58-66

Authors: DUGGAN ME NAYLOROLSEN AM PERKINS JJ ANDERSON PS CHANG CTC COOK JJ GOULD RJ IHLE NC HARTMAN GD LYNCH JJ LYNCH RJ MANNO PD SCHAFFER LW SMITH RL
Citation: Me. Duggan et al., NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS .7. DESIGN AND SYNTHESIS OF A POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 38(17), 1995, pp. 3332-3341

Authors: CHANG LL ASHTON WT FLANAGAN KL NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ BENDESKY RJ CHEN TB FAUST KA KLING PJ SCHAFFER LW SCHORN TW ZINGARO GJ CHANG RSL LOTTI VJ KIVLIGHN SD SIEGL PKS
Citation: Ll. Chang et al., TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 115-120

Authors: SIEGL PKS GABEL RA ZINGARO GJ SCHORN T HARVEY C ARBEGAST P BROTEN TP SCHAFFER LW CHAKRAVARTY PK GREENLEE W NAVLOR E PATCHETT AA KIVLIGHN SD
Citation: Pks. Siegl et al., IN-VIVO PHARMACOLOGY AND ANTIHYPERTENSIVE ACTIVITY OF L-159,282 (MK-996) A NONPEPTIDE ANGIOTENSIN-II (A-II) RECEPTOR ANTAGONIST, The FASEB journal, 8(5), 1994, pp. 10000881-10000881

Authors: CHAKRAVARTY PK NAYLOR EM CHEN A CHANG RSL CHEN TB FAUST KA LOTTI VJ KIVLIGHN SD GABLE RA ZINGARO GJ SCHORN TW SCHAFFER LW BROTEN TP SIEGL PKS PATCHETT AA GREENLEE WJ
Citation: Pk. Chakravarty et al., A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 37(24), 1994, pp. 4068-4072

Authors: SCHAFFER LW DAVIDSON JT SIEGL PKS GOULD RJ NUTT RF BRADY SF CONNOLLY TM
Citation: Lw. Schaffer et al., RECOMBINANT LEECH ANTIPLATELET PROTEIN PREVENTS COLLAGEN-MEDIATED PLATELET-AGGREGATION BUT NOT COLLAGEN GRAFT THROMBOSIS IN BABOONS, Arteriosclerosis and thrombosis, 13(11), 1993, pp. 1593-1601

Authors: HARVEY CM NUTT EM SIEGL PKS SCHAFFER LW
Citation: Cm. Harvey et al., ABBREVIATED THERAPY WITH THE SELECTIVE FACTOR-XA INHIBITOR, RECOMBINANT TICK ANTICOAGULANT PEPTIDE (RTAP), PROVIDES SUSTAINED ANTITHROMBOTIC EFFICACY IN A BABOON MODEL OF VASCULAR GRAFT THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 569-569

Authors: SCHAFFER LW DAVIDSON JT CONNOLLY TM GOULD RJ NUTT RF BRADY SF SIEGL PKS
Citation: Lw. Schaffer et al., EFFECTS OF RECOMBINANT LEECH ANTIPLATELET PROTEIN (RLAPP), A SPECIFICINHIBITOR OF COLLAGEN-MEDIATED PLATELET-AGGREGATION, ON VASCULAR GRAFT THROMBOSIS IN ANESTHETIZED BABOONS, Thrombosis and haemostasis, 69(6), 1993, pp. 586-586
Risultati: 1-9 |